When is the use of Nebido® contraindicated?
Like every androgen therapy, the use of Nebido® is contraindicated in diagnosed or suspected carcinoma of the prostate or of the male mammary gland; hypercalcemia accompanying malignant tumors, past or present liver tumors; hypersensitivity to the active substance or to any of the excipients. Nebido® is not indicated for use in children and adolescents and it has not been evaluated clinically in males under 18 years of age. Furthermore, the use of Nebido® in women is contra-indicated. • Side efects The most frequent side effects of Nebido® observed are acne and injection site pain. These reactions are generally mild and transient. Other common side effects observed are typical of testosterone (e.g. polycythemia, weigth increase, hot flushes, prostate specific antigen increased, prostate examination abnormal, benign prostate hyperplasia). Pulmonary microembolism of oily solutions can in rare cases lead to signs and symptoms such as cough, dyspnea, malaise, hyperhidrosis, chest pain, diz
